HIGHLIGHTS
- who: Guo-Sheng Li from the Medicine, The First Affiliated Hospital of Guangxi Medical University, No, Peopleu2019s Republic of China have published the Article: Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers, in the Journal: (JOURNAL)
- what: The authors assessed CDKN2C expression levels in SCLC and non-SCLC by using in-house data and data from Gene Expression Omnibus. Taking the current studies, the authors infer that: the protective prognosis roles for some cancers (e_g, CESC and THYM) reflect the typical function of CDKN2C . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.